QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer 期刊论文 BMC CANCER, 2017, 卷号: 17 作者:  Liu, Xin;  Guo, Weijian;  Zhang, Wen;  Yin, Jiliang;  Zhang, Jun 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Cetuximab  FOLFIRI  Gastric cancer  Biomarker   Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer 期刊论文 MOLECULAR AND CLINICAL ONCOLOGY, 2017, 卷号: 6, 期号: 2 作者:  Yu, Hui;  Liu, Fang;  Sansas, Benoit;  Kang, Bin;  Preville, Xavier 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 killer-cell immunoglobulin-like receptor  human leukocyte antigen  non-small-cell lung cancer  prognosis   Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors 期刊论文 ONCOTARGETS AND THERAPY, 2017, 卷号: 10 作者:  Sun, Si;  Yu, Hui;  Wang, Huijie;  Zhao, Xinmin;  Zhao, Xintai 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 BIM  EGFR  NSCLC  clinical outcome   Efficacy and safety of Endostar (recombinant human endostatin hormone) combined with docetaxel as second-or third-line therapy for patients with non-small-cell lung cancer 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 1 作者:  Ji, Dongmei;  Wang, Jialei;  Yu, Hui;  Wu, Xianghua;  Wang, Huijie 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Carcinoma  non-small-cell lung  chemotherapy  second or third line therapy  endostar protein  docetaxel   Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 49 作者:  Qiao, Jie;  Zhao, Xinmin;  Yu, Hui;  Zhao, Jing;  Wu, Xianghua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 non-small-cell lung cancer  pemetrexed  carboplatin  elderly  maintenance therapy   The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma 期刊论文 MEDICINE, 2017, 卷号: 96, 期号: 15 作者:  Yang, Zhizhang;  Qiu, Weizhe;  Zhang, Long;  Zhang, Suxia;  Wu, Yunjin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 diffuse large B-cell lymphoma  programmed cell death 1  programmed cell death ligand 1  TP63   Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis 期刊论文 CANCER RESEARCH, 2017, 卷号: 77, 期号: 6 作者:  Wu, Yong;  Yu, Xiaoting;  Yi, Xianghua;  Wu, Ke;  Dwabe, Sami 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Lower levels of glucagon-like peptide 1 are an independent risk factor for mild cognitive dysfunction in type 2 diabetes 会议论文 21st Scientific Meeting of the Chinese-Diabetes-Society, NOV 22-25, 2017 作者:  Wu, Peipei;  Zhuang, Xianghua;  Sun, Aili;  Zhang, Yuan;  Chen, Shihong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/31